NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $308 | -99.9% | 3,393 | -9.6% | 0.01% | 0.0% |
| Q3 2022 | $285,000 | -99.6% | 3,752 | -99.5% | 0.01% | -99.5% |
| Q2 2022 | $63,547,000 | -6.8% | 751,770 | -3.2% | 0.99% | +1.7% |
| Q1 2022 | $68,151,000 | +0.7% | 776,652 | +0.4% | 0.98% | +9.9% |
| Q4 2021 | $67,647,000 | -5.2% | 773,372 | -11.4% | 0.89% | -9.7% |
| Q3 2021 | $71,353,000 | -11.1% | 872,500 | -0.9% | 0.98% | -9.3% |
| Q2 2021 | $80,293,000 | +24.0% | 880,025 | +16.2% | 1.08% | +19.9% |
| Q1 2021 | $64,731,000 | -22.3% | 757,265 | -14.2% | 0.90% | -26.2% |
| Q4 2020 | $83,316,000 | +12.9% | 882,303 | +4.0% | 1.22% | -0.7% |
| Q3 2020 | $73,776,000 | +6.8% | 848,388 | +7.2% | 1.23% | +1.7% |
| Q2 2020 | $69,091,000 | -2.9% | 791,056 | -8.3% | 1.21% | -17.1% |
| Q1 2020 | $71,155,000 | -14.4% | 863,008 | -1.7% | 1.46% | +14.6% |
| Q4 2019 | $83,105,000 | – | 877,651 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |